Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: LaNova Medicines Zhejiang Co., Ltd.
Condition: Malignant Neoplasms of Digestive Organs
NCT05934331
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal | rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.